Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sultiam (N03Ax03), Only Film-Coated Tablets, Within The Framework Of A So-Called Open-House Model.

AOK Rheinland-Pfalz Saarland - Die Gesundheitskasse Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sultiam (N03Ax03), Only Film-Coated Tablets, Within The Framework Of A So-Called Open-House Model. in . The tender was released on Sep 17, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sultiam (N03Ax03), Only Film-Coated Tablets, Within The Framework Of A So-Called Open-House Model.

Deadline - Aug 31, 2026

IT reference number - 93420992

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  IT Ref Id - 93420992

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient sultiam (N03AX03), only film-coated tablets, within the period fro m November 1, 2024 to October 31, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list in accordance with Section 35 Paragraph 5a SGB V (medicines for children) are excluded.notice_title: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Ac

It Ref Id - 93420992

Deadline - Aug 31, 2026

Share

Similar Tenders :